A U.S. pharmaceutical holding company is stealing the show so far during the mid-week session following an announcement that the company’s board of directors has authorized...

To read the full story on AllPennyStocks.com, click here.

Scilex (NASDAQ:SCLXW)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025 Plus de graphiques de la Bourse Scilex
Scilex (NASDAQ:SCLXW)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025 Plus de graphiques de la Bourse Scilex